You are using an older browser version. Please use a supported version for the best MSN experience.

FDA panel says vaccine benefits outweigh risks for young kids

CNBC's Meg Tirrell joins Shep Smith to report on an FDA panel's decision to recommend the vaccine for children ages 5 to 11.
image beaconimage beaconimage beacon